<- Go Home

Embrex LLC

Embrex LLC operates as a biotechnology company that develops in-ovo vaccination devices for the poultry industry in USA and internationally. Its product line includes Inovoject system, a biodevice for the protection of chicks from disease challenges; Inovoject M, a biodevice designed to meet the needs of smaller hatcheries that do not process enough eggs; and Inovoject Vaccine Saver system that enhances the productivity of the in-ovo vaccination process. The company also offers an egg remover system that identifies and removes infertile and early dead eggs; and a chick counter, a biodevice system for chick counting through automation. Additionally, the company also offers vaccine manufacturers and research institutes, with a range of devices, including VMD ERH and EMBREX VMD ERV device that uses an infra-red system in conjunction with a heartbeat detector to identify infertile eggs and/or embryos that are no longer alive; VMD VAI biodevice that is used by pharmaceutical companies to manufacture a range of human and animal vaccines, including human influenza vaccine; and VMD VMI biodevice for egg-based vaccine production. The company was founded in 1992 and is based in Parsippany, New Jersey. Embrex LLC operates as a subsidiary of Zoetis Inc.

Market Cap

$142.7M

Volume

25.5K

Cash and Equivalents

$3.0M

EBITDA

$11.4M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$31.6M

Profit Margin

58.11%

52 Week High

$17.00

52 Week Low

$8.70

Dividend

N/A

Price / Book Value

2.47

Price / Earnings

54.68

Price / Tangible Book Value

2.80

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$3.8M

Return on Equity

4.79%

Return on Assets

3.37

Cash and Short Term Investments

$3.0M

Debt

$9.9M

Equity

$57.4M

Revenue

$54.4M

Unlevered FCF

-$2.3M

Sector

Biotechnology

Category

N/A

Company Stock Pitches